Back

Role of SGLT2I in improving right ventricular systolic function in patients with HFpEF

28 August 2026 (16:35 - 16:45)
Organised by: Logo
Congress Presentation Part of: Towards deeper phenotyping in HFpEF and pulmonary hypertension Heart Failure with Preserved Ejection Fraction (HFpEF) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Hesham Salaheldin

Cairo university, Cairo (Egypt)

5 More presentations in this session

Presentation thumbnail
Imbalanced ω-6/ω-3 polyunsaturated fatty acid metabolism promotes HFpEF progression via the ANGPTL4/LPL axis-mediated lipotoxicity
Doctor Z. Zhang (Xi'an, CN)
Abstract Slides Video
Presentation thumbnail
Persistent right ventricular-pulmonary arterial coupling dysfunction and its association with iron metabolism in patients with heart failure
Doctor Y. Fukunaga (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Echocardiographic markers of residual pulmonary vascular disease and clinical risk after transcatheter mitral valve edge-to-edge repair
Doctor F. Nunez Guzman (Hackensack, US)
Abstract Slides Video
Presentation thumbnail
Immune–metabolic crosstalk between T cells and interstitial macrophages drives pulmonary vascular remodeling in cardiometabolic HFpEF
Ms V. Masciovecchio (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
HFpEF: serum oxylipin analyses and myocardial biopsy-based transcriptomics indicate distinct signatures of pulmonary vascular remodeling
Associate Professor F. Raza (Madison, US)
Abstract Slides Video

Access the full session

Session thumbnail
Towards deeper phenotyping in HFpEF and pulmonary hypertension
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 16:35 CET
You may be interested in
thumbnail
Congress Presentation
Clinical outcomes and safety of SGLT2 inhibitor therapy in patients with a systemic right ventricle and heart failure: a pre-post analysis from the ACHIEVE-SGLT2i registry
28 August 2026
thumbnail
Congress Presentation
Advances in the treatment of HFpEF
20 May 2025
thumbnail
Congress Presentation
Impact of Dapaglizofin on right ventricular function and pulmonary pressure: a secondary analysis of the RIVED registry
11 May 2026
thumbnail
Congress Presentation
Short-term effects of SGLT2 inhibitors on myocardial extracellular volume, left ventricular function and inflammation in patients with HFpEF and diabetes mellitus
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources